Catalysis Driven by an Amyloid-Substrate Complex

24 July 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Amyloid catalysis is an emerging area of research. Here, we report a new catalysis system, i.e., catalysis driven by amyloid-substrate complex (CASL), by exploiting amyloid binding with the ligands. The ammonium ion attached to the amyloid-binding motif was activated by its proximity to the amyloid catalyst, formed by Ac-Asn-Phe-Gly-Ala-Ile-Leu-NH2 (NL6) derived from islet amyloid polypeptide (IAPP), thereby promoting amine modifications in the acidic buffer. Consistent with the mode of action of CASL, the affinity of the substrates with amyloid catalysts correlated with the reaction yields. In addition, the direction of the amine extension from the amyloid-binding site markedly influenced the reaction progress. Crystallographic analysis and amide-to-ester substitution of the amyloid catalysts indicated that the carbonyl oxygen of the Phe–Gly amide bond of NL6 played a key role in activating the substrate amine via forming a hydrogen bond. With CASL, we succeeded in the selective conversion of substrates possessing equivalently reactive amine functionalities and introduced a new reaction scope (various amine modifications) to catalytic reactions using amyloids. The substrate-selective conversion ability of CASL significantly expands the applicability of catalytic amyloids in diverse research fields, including chemical biology and materials science.

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Figures S1-S7, HPLC charts for all reaction entries underlying the conversion yields to the products, experimental details, and synthetic protocols
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.
Comment number 1, Elad Arad: Jul 28, 2023, 19:37

Nice work. It is tightly related to other works on natural amyloid-derived catalysis such as the following: https://www.biorxiv.org/content/10.1101/2023.02.01.526669v1.abstract https://scholar.google.co.il/citations?view_op=view_citation&hl=iw&user=Sj4xLeEAAAAJ&sortby=pubdate&citation_for_view=Sj4xLeEAAAAJ:hqOjcs7Dif8C https://scholar.google.co.il/citations?view_op=view_citation&hl=iw&user=Sj4xLeEAAAAJ&sortby=pubdate&citation_for_view=Sj4xLeEAAAAJ:_FxGoFyzp5QC https://scholar.google.co.il/citations?view_op=view_citation&hl=iw&user=Sj4xLeEAAAAJ&sortby=pubdate&citation_for_view=Sj4xLeEAAAAJ:UebtZRa9Y70C https://pubmed.ncbi.nlm.nih.gov/36745416/ I think the comparison between the different sequences is fascinating. Also, I wonder whether all amyloids act in the same nucleophilic attack mechanism.